Former Editorial Board
Yong Chan Ahn, MD, PhD
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Karen S. Anderson, MD, PhD
Professor, Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, Arizona, USA
Jean-Pierre Armand MD, MSc
Institut Gustave Roussy, Cancer Campus Grand Paris, France
Yung-Jue Bang, MD, PhD
Seoul National University College of Medicine; Biomedical Research Institute, Seoul National University Hospital, Korea
Robert C. Bast
Vice President for Translational Research, UT MD Anderson Cancer Center, USA
Tracy Batchelor, MD, MPH
Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital
Co-Leader, Brain Cancer Program, Harvard Medical School; Giovanni Armenise - Harvard Professor of Neurology, Harvard Medical School, Boston, Massachusetts, USA
Priscilla Kaliopi Brastianos, MD
Central Nervous System Metastasis Program; Divisions of Hematology/Oncology and Neuro-Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
Antonio C Buzaid, MD
Centro Oncológico Antonio Ermírio de Moras, Hospital São José, Rua Martiniano de Carvalho,São Paulo, Brazil
James CS Chim
Department of Medicine, Queen Mary Hospital University of Hong Kong, Hong Kong, China
Melvin L.K. Chua
Division of Radiation Oncology, National Cancer Centre, Duke-NUS Graduate Medical School, Singapore
Christian Dittrich, MD
LBI-ACR VIEnna and ACR-ITR VIEnna, Center for Oncology and Haematology, Kaiser Franz Josef-Spital, Vienna, Austria
Junji Furuse, MD, PhD
Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan
David Goldstein, MBBS, FRACP, FRCP (UK)
Department of Medical Oncology, Prince of Wales Hospital, Randwick, Australia
Jun Guo, MD, PhD
Department of Melanoma & Renal Cancer, Peking University Cancer Hospital & Institute, Beijing, China
Noriyuki Katsumata, MD
Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa, Japan
Lin Kong, MD
Head of the Head/Neck and CNS Oncology Service at the Shanghai Proton and Heavy Ion Center (SPHIC), Shanghai, China
Ava Kwong, MBBS, BSc (St Andrews), PhD, FRCS (Edin), FRCS,FHKAM (Surgery), FCSHK
The University of Hong Kong and The University of Hong Kong-Shen Zhen Hospital, China; Department & Faculty of Medicine, The University of Hong Kong; Chairman, The Hong Kong Hereditary Breast Cancer Family Registry; Hong Kong Sanatorium and Hospital, China
Denis Lacombe, MD, MSC
EORTC Headquarters, Brussels, Belgium
J. Jack Lee, PhD
Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Ning Liao, MD, PhD
Director, Department of Breast Cancer, Cancer Center, Guangdong General Hospital, Guangzhou, China
Ke Liu, MD, PhD
Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA
Brigette Ma, MD, MBBS (Hon), FRACP, FHKCM, FHKAM
Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
Philippe Metellus, MD, PhD
Department of Neurosurgery, Clairval Hospital Center, Generale de Sante, Marseille , France
Kazuhiko Nakagawa, MD, PhD
Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama, Osaka, Japan
Yangmin Ning, MD, PhD
Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
Kazuto Nishio, MD, PhD
Department of Genome Biology, Kinki University Faculty of Medicine, Osaka, Japan
Masahiko Nishiyama, MD, PhD
Department of Molecular Pharmacology & Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Ken O’Byrne, MD
Department of Clinical and Medical Oncology, St James’s Hospital and Trinity College, Dublin, Ireland
Matthias Preusser
Department of Medicine I, Comprehensive Cancer Center-CNS Unit, Medical University of Vienna, Vienna, Austria
Daniel J. Sargent, PhD (Statistics in Oncology Clinical Trials, 1970-2016)
Department of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
Wenru Song, MD, PhD
Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, California, USA
Weijing Sun, MD, FACP
Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
Sandra M. Swain, MD, FACP
Washington Cancer Institute, Medstar Washington Hospital Center, Washington DC, USA
Kazuo Tamura, MD
Division of Oncology, Hematology, and Infectious Diseases, Department of Medicine, Fukuoka University School of Medicine, Fukuoka, Japan
Alan P. Venook, MD
Department of Medicine, UCSF School of Medicine, University of California, San Francisco, California, USA
William C. Wood, MD, FACS, FRCS Eng (Hon), FRCS Glasg
Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia, USA
Yasuhide Yamada, MD
Director, NCGM Comprehensive Cancer Center, National Center for Global Health and Medicine, Tokyo, Japan
Sherry X. Yang, MD, PhD
National Cancer Institute, National Institutes of Health, USA
RuiRong Yuan, MD, PhD
Department of Medicine, VA Medical Center, UMDNJ-New Jersey Medical School, Newark, New Jersey, USA
